Overview

Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers

Status:
Completed
Trial end date:
2009-06-15
Target enrollment:
Participant gender:
Summary
Evaluate the Pharmacokinetics of Mucinex® 600 mg Extended-Release Bi-Layer Tablet in Normal Healthy Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Reckitt Benckiser Inc.
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination
Guaifenesin
Phenylpropanolamine